| Followers | 236 |
| Posts | 10817 |
| Boards Moderated | 0 |
| Alias Born | 07/17/2006 |
Monday, December 02, 2019 1:00:28 PM
raf...
I remember you calling yourself an Ace poker player...If so...why are you advocating for poor play...If the pot odds say call.. If the odds say calling is correct then calling is good poker...If you are in poker game you can not afford and make decisions based on your wallet then you are just playing over your head and that is bad poker..
I am not against buyouts per say...I am against buyouts based on immediate gratification (something we discussed earlier after the R-I results). I am also sympathetic to personal situations in the market (but these situations do not pertain to poker games)...If someone sold 25% 0f his shares after the R-I results at a PPS of $14...because he wanted to insure his children went to college...I'm fine with that...as it represents a windfall that is unlikely to occur in the future...But for those who are not in a special situation..Rooting for a buyout which would be multiples less than the company holding and not selling because they have "Ants in their pants" Well It is not good market play..I have no sympathy for any of these guys who have come on the board after the R-I results...
I go back to the "Stock Broker" era...and I was always a shooter..I had a good old fashion Broker..Bruce Rocknowski (RIP)..Those were telephone days..and Bruce knew every Wall Street joke ever told..and every affirism...He was a heavy drinker and proved it by dying of Pancreatitis..We had some times...I lost $650,000 while playing a round of golf on one of the Disney courses on vacation with my wife and kids..And that was not Amarin fluctuation money..That was gone for good...and it hurt bad...The only salvation was I was up $850,000 on the stock..(Genzyme Tissue Repair)...When the stock was going up it was like Monopoly Money...When I lost it it was like having my guts pulled out...Worst Disney Vacation ever..
I have not done that again..The problem was I did not understand the treatment and the science and I vowed that would never happen again and it hasn't....
":>) JL
I remember you calling yourself an Ace poker player...If so...why are you advocating for poor play...If the pot odds say call.. If the odds say calling is correct then calling is good poker...If you are in poker game you can not afford and make decisions based on your wallet then you are just playing over your head and that is bad poker..
I am not against buyouts per say...I am against buyouts based on immediate gratification (something we discussed earlier after the R-I results). I am also sympathetic to personal situations in the market (but these situations do not pertain to poker games)...If someone sold 25% 0f his shares after the R-I results at a PPS of $14...because he wanted to insure his children went to college...I'm fine with that...as it represents a windfall that is unlikely to occur in the future...But for those who are not in a special situation..Rooting for a buyout which would be multiples less than the company holding and not selling because they have "Ants in their pants" Well It is not good market play..I have no sympathy for any of these guys who have come on the board after the R-I results...
I go back to the "Stock Broker" era...and I was always a shooter..I had a good old fashion Broker..Bruce Rocknowski (RIP)..Those were telephone days..and Bruce knew every Wall Street joke ever told..and every affirism...He was a heavy drinker and proved it by dying of Pancreatitis..We had some times...I lost $650,000 while playing a round of golf on one of the Disney courses on vacation with my wife and kids..And that was not Amarin fluctuation money..That was gone for good...and it hurt bad...The only salvation was I was up $850,000 on the stock..(Genzyme Tissue Repair)...When the stock was going up it was like Monopoly Money...When I lost it it was like having my guts pulled out...Worst Disney Vacation ever..
I have not done that again..The problem was I did not understand the treatment and the science and I vowed that would never happen again and it hasn't....
":>) JL
Recent AMRN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026 • GlobeNewswire Inc. • 02/11/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:06 AM
